SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals
REGN 787.37+3.4%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: The Ox who wrote (1854)1/12/2016 2:08:38 PM
From: Miljenko Zuanic  Read Replies (1) of 3559
 
Point is, "Mr. Market" striped +$14B of the REGN MC in few days!
So, WAS REGN MC at 15-Yend overblown form/by "GREEDY" analysts(speculators), or REGN perspective and BM changed dramatically in few days??? For instance Praluent 16/17-perspective or Eylea-grow due to price pressure from cheaper Avastin??!!

Pressure on bio-business continue and will intensify, IMO, but I can blame equally greedy comps with unrealistic price-tag and ANALYST with even more UNREALISTIC stock price target.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext